Literature DB >> 17361035

Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains.

Pilar Gómez-Ramos1, M Asunción Morán.   

Abstract

Autopsied brain tissue from Alzheimer's disease patients and old non-demented controls was studied after immunocytochemistry with the 4G8 monoclonal antibody that recognizes amyloid-beta peptides. Intraneuronal 4G8-positive reaction product was detected in all of the studied brains. The same brain regions in the Alzheimer's disease samples consistently showed both more immunopositive neurons and more stained reaction product per neuron than those from the non-demented brains. Ultrastructurally, the immunopositive reaction product accumulated in clusters of cytoplasmic elements that had a lipofuscin-like appearance, showed a fibrogranular content and were also closely apposed to lipid droplets located either on their periphery or within them. The most strongly 4G8-immunopositive elements had diffuse limits with their fibrogranular content free in the cytoplasm, whereas elements either without or showing only light immunoreaction had a limiting membrane. All immunopositive neurons displayed a similar pattern of clumping heterochromatin. The hypothetical neurotoxic role of intraneuronal amyloid-beta peptides free in the cytoplasm is discussed as is the possible relationship between the amyloid-beta peptides recognized by the 4G8 antibody and the lipid droplets which would presumably contain esterified cholesterol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361035     DOI: 10.3233/jad-2007-11109

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  35 in total

1.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

Authors:  H N Dawson; V Cantillana; M Jansen; H Wang; M P Vitek; D M Wilcock; J R Lynch; D T Laskowitz
Journal:  Neuroscience       Date:  2010-04-29       Impact factor: 3.590

Review 2.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

3.  Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23.

Authors:  Kazuma Murakami; Yuko Horikoshi-Sakuraba; Nakaba Murata; Yoshihiro Noda; Yuichi Masuda; Noriaki Kinoshita; Hiroyuki Hatsuta; Shigeo Murayama; Takuji Shirasawa; Takahiko Shimizu; Kazuhiro Irie
Journal:  ACS Chem Neurosci       Date:  2010-09-28       Impact factor: 4.418

4.  Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress.

Authors:  Linda L Lee; Hnin H Aung; Dennis W Wilson; Steven E Anderson; John C Rutledge; Jennifer M Rutkowsky
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-11       Impact factor: 4.249

Review 5.  On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis.

Authors:  Estela Area-Gomez; Eric A Schon
Journal:  FASEB J       Date:  2017-03       Impact factor: 5.191

6.  Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.

Authors:  Joungil Choi; Avinash Ravipati; Vamshi Nimmagadda; Manfred Schubert; Rudolph J Castellani; James W Russell
Journal:  Mitochondrion       Date:  2014-09-23       Impact factor: 4.160

7.  Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.

Authors:  Mihyun Bae; Neha Patel; Haoxing Xu; Mingwaoh Lee; Kumiko Tominaga-Yamanaka; Avindra Nath; Jonathan Geiger; Myriam Gorospe; Mark P Mattson; Norman J Haughey
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

Review 8.  Mitochondria-associated ER membranes and Alzheimer disease.

Authors:  Estela Area-Gomez; Eric A Schon
Journal:  Curr Opin Genet Dev       Date:  2016-05-25       Impact factor: 5.578

Review 9.  Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.

Authors:  Roberto Cappai; Kevin J Barnham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

10.  An update on the toxicity of Abeta in Alzheimer's disease.

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock; Roberto Cappai
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.